e-learning
resources
Stockholm 2002
Sunday 15.09.2002
Thoracic oncology: biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of angiogenesis, assessed by microvessel count (MVC), on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
A. P. Meert, B. Martin, M. Paesmans, J. M. Verdebout, T. Berghmans, J. J. Lafitte, P. Delmotte, C. Mascaux, J. P. Sculier (Brussels, Belgium; Lille, France)
Source:
Annual Congress 2002 - Thoracic oncology: biology
Session:
Thoracic oncology: biology
Session type:
Oral Presentation
Number:
140
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. P. Meert, B. Martin, M. Paesmans, J. M. Verdebout, T. Berghmans, J. J. Lafitte, P. Delmotte, C. Mascaux, J. P. Sculier (Brussels, Belgium; Lille, France). The role of angiogenesis, assessed by microvessel count (MVC), on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Eur Respir J 2002; 20: Suppl. 38, 140
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
The role of EGFR expression in the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
Source: Eur Respir J 2001; 18: Suppl. 33, 478s
Year: 2001
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
Source: Eur Respir J 2001; 18: 705-719
Year: 2001
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
Source: Eur Respir J 2002; 20: 975-981
Year: 2002
Role of ras protoncogene in survival of patients with lung cancer: a systematic literature review and meta-analysis
Source: Eur Respir J 2004; 24: Suppl. 48, 478s
Year: 2004
COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations
Source: Eur Respir J 2011; 39: 9-28
Year: 2012
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations
Source: Eur Respir J 2012; 39: 9-28
Year: 2012
Late-breaking abstract: Is primary tumour standardized uptake value (SUV) an independent prognostic factor for non small cell lung cancer (NSCLC)? A meta-analysis based on individual data
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis.
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021
Relevance of clinical TNM-staging in small cell lung cancer (SCLC) for survival – A retrospective case study in 633 patients
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010
Validation and comparison of several published prognostic systems for patients with small cell lung cancer
Source: Eur Respir J 2011; 38: 657-663
Year: 2011
Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019
A meta-analysis assessing the prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
Source: Eur Respir J 2001; 18: Suppl. 33, 319s
Year: 2001
Systematic review of the effect of chemotherapy on quality of life (QoL) and symptom control in patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Lung cancer treatment
Year: 2006
Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer (ED SCLC)
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019
Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis
Source: ERJ Open Res, 5 (4) 00179-2019; 10.1183/23120541.00179-2019
Year: 2019
The prognosis of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in lung cancer and the association with treatment: a retrospective study>
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Limited role of Ki-67 in lung carcinoid tumor patients predicting overall short-term survival,A single institution experience
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
A retrospective study of the cause and impact of delayed diagnosis of lung cancer (LC)
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept